Erschienen in:
Case Reports in Ophthalmology, 9 (2018) 2, Seite 357-364
Sprache:
Englisch
DOI:
10.1159/000491487
ISSN:
1663-2699
Entstehung:
Anmerkungen:
Beschreibung:
<b><i>Aim:</i></b> To investigate the efficacy of intravitreal injection of ocriplasmin (JETREA®) in the treatment of vitreomacular traction (VMT). <b><i>Materials and Methods:</i></b> An 81-year-old man with VMT associated with central retinal vein occlusion in his left eye, was treated with a single intravitreal injection of ocriplasmin (25 μg). Best corrected visual acuity (BCVA), ocular fundus, and optical coherence tomography were examined before and after treatment. <b><i>Results:</i></b> Complete release of VMT produced a reduction of central macular thickness, ranging from 459 to 141 μm. BCVA remained stable. <b><i>Discussion and Conclusions:</i></b> The use of ocriplasmin was effective in the treatment of VMT. Ocriplasmin represents a valid alternative to conventional pars plana vitrectomy.